Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,851–3,875 of 7,816 matching trials · page 155 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation NCT05321498 XPro1595; Placebo |
PHASE2 other |
WITHDRAWN | 0 | Inmune Bio, Inc. INDUSTRY |
2023-09-28 |
|
Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease NCT05709301 Donepezil Hydrochloride; Placebo |
PHASE2 symptomatic-cholinergic |
UNKNOWN | 120 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau OTHER |
2023-09-28 |
|
Development of the Virtual Unified Huntington's Disease Rating Scale NCT05748288 Runs in: United States · 17 sites |
NA other |
COMPLETED | 60 | Huntington Study Group NETWORK |
2023-09-28 |
|
E-health Enhanced Motor-cognitive Training for AED Discharged Older Adults With Cognitive Frailty NCT05750121 E-health enhanced motor-cognitive training Runs in: Hong Kong · 1 site |
NA other |
UNKNOWN | 40 | The Hong Kong Polytechnic University OTHER |
2023-09-28 |
|
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study NCT06058234 Monoclonal Antibodies Directed Against Amyloid for the Treatment of... Runs in: United States · 1 site |
NA other |
RECRUITING | 8,680 | Centers for Medicare and Medicaid Services/ Coverage and Analysis Group OTHER_GOV |
2023-09-28 |
|
Effects of Transcutaneous Electrical Nerve Stimulation (TENS) to Improve the Cognitive Functions in Older Adults NCT05408689 T1 TENS; Concha TENS; Control Runs in: Hong Kong · 1 site |
NA other |
COMPLETED | 90 | The Hong Kong Polytechnic University OTHER |
2023-09-22 |
|
Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease NCT02752750 MRI |
NA other |
UNKNOWN | 50 | Medical University of Graz OTHER |
2023-09-21 |
|
Systematic Multi-domain Alzheimer's Risk Reduction Trial NCT03683394 SMARRT Intervention; Health Education Intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 172 | Kaiser Permanente OTHER |
2023-09-21 |
|
An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging NCT05058950 Runs in: United States · 1 site |
NA other |
TERMINATED | 22,720 | Biogen INDUSTRY |
2023-09-21 |
|
Mindfulness-Based VR for Family Caregivers of People With Dementia NCT06034249 Mindfulness-Based VR; Audio Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 16 | Taipei Medical University OTHER |
2023-09-21 |
|
Cognitive Impairment and Fatigue After Mild to Moderate COVID-19 NCT06042530 Neuropsychological investigation; Optometric investigation; Magneti... Runs in: Sweden · 1 site |
NA other |
UNKNOWN | 100 | Danderyd Hospital OTHER |
2023-09-21 |
|
A Feasibility Study of Online Psychoeducation for Family Caregivers of People With Dementia NCT06042634 Online psychoeducation; Face-to-face psychoeducation Runs in: Hong Kong · 1 site |
NA other |
COMPLETED | 60 | Chinese University of Hong Kong OTHER |
2023-09-21 |
|
Feasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease NCT06047340 G:DATA, dementia screen videogame Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 30 | Ascentys Ltd INDUSTRY |
2023-09-21 |
|
Benefit of Virtual Reality Headset Use on Apathy in Older Adults With Major Neurocognitive Disorders NCT06047522 Casque Lumeen Runs in: France · 6 sites |
NA other |
UNKNOWN | 30 | RIVAGES OTHER |
2023-09-21 |
|
Virtual Reality Training for Aggression Control NCT06047587 VR-TrAC; Care as Usual Runs in: Netherlands · 1 site |
NA other |
UNKNOWN | 128 | University Medical Center Groningen OTHER |
2023-09-21 |
|
18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis NCT06048601 18F-florbetaben PET/CT Runs in: Italy · 1 site |
NA other |
UNKNOWN | 150 | Fondazione Toscana Gabriele Monasterio OTHER |
2023-09-21 |
|
Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control NCT02483572 Functional Communication Training Runs in: United States · 1 site |
NA other |
TERMINATED | 4 | University of Nebraska OTHER |
2023-09-18 |
|
Computer Training and Transcranial Direct Current Stimulation for Cognition in HIV NCT03440840 Transcranial Direct Current Stimulation (tDCS); Computer-based Cogn... Runs in: United States · 1 site |
NA other |
COMPLETED | 46 | Nova Southeastern University OTHER |
2023-09-18 |
|
A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type NCT03548584 Brexpiprazole; Placebo Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 345 | Otsuka Pharmaceutical Development & Commercialization, Inc. INDUSTRY |
2023-09-18 |
|
Wii-fit for Activity, Balance and Gait in Assisted Living NCT01000038 Wii-Fit intervention; Walking Runs in: United States · 1 site |
NA other |
COMPLETED | 22 | University of Nebraska OTHER |
2023-09-15 |
|
Clinical Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients NCT05043675 [18F]APN-1607 Runs in: China · 1 site |
EARLY_PHASE1 other |
UNKNOWN | 6 | Nanjing First Hospital, Nanjing Medical University OTHER |
2023-09-14 |
|
Immunohistochemical Study of Neurodegenerative Diseases NCT05518409 Detection of cytof in peripheral PBMC; Donepezil for patients with ... Runs in: China · 1 site |
NA symptomatic-cholinergic |
UNKNOWN | 100 | First Affiliated Hospital of Zhejiang University OTHER |
2023-09-14 |
|
Premature Enhanced Automated Capture of Comfort Knowledge NCT06037629 Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 100 | Newcastle University OTHER |
2023-09-14 |
|
Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia (Allena-Mente). NCT01793493 Cognitive stimulation; Sanitary education Runs in: Italy · 1 site |
NA other |
COMPLETED | 121 | Fondazione Golgi Cenci OTHER |
2023-09-13 |
|
Addressing Dementia Via Agitation-Centered Evaluation NCT03226522 AXS-05; Bupropion; Placebo Runs in: Australia; United States · 78 sites |
PHASE2|PHASE3 other |
COMPLETED | 366 | Axsome Therapeutics, Inc. INDUSTRY |
2023-09-13 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial